Bavarian Nordic to Present New Evidence for Mechanism of

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

May 15, 2014 at 1:30 AM

Bavarian Nordic to Present New Evidence for Mechanism of Action for PROSTVAC Immunotherapy at the 2014 ASCO Annual Meeting

KVISTGAARD, Denmark, May 15, 2014 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today a paper featuring the Company's lead cancer immunotherapy candidate PROSTVAC® will be presented as a poster at the 2014 ASCO Annual Meeting in Chicago, IL from May 30 to June 3. The presented work provides new evidence elucidating the mechanism of action of PROSTVAC immunotherapy for prostate cancer. The abstract, "PROSTVAC, PSA-targeted Immunotherapy - New Evidence for Mechanism of Action" will be presented during the General Poster Session, Developmental Therapeutics: Immunotherapy, Sunday, June 1, 2014 from 8:00AM to 11:45 AM CDT. The abstract can be seen at the ASCO Annual Meeting website: http://abstracts.asco.org/144/AbstView_144_134733.html. Abstract Highlights: * Patients administered PROSTVAC immunotherapy showed evidence of significant enhancement of PSA-specific T cell responses compared to subjects administered placebo viral vectors. * Increased numbers and improved quality of activated PSA-specific T cells were observed with the PROSTVAC prime and boost regimen compared to single vector regimens in preclinical models. * The authors conclude that PROSTVAC immunotherapy elicits broad, highly functional T cell immunity to PSA, which then expands to include immune responses against endogenous tumor antigens not targeted by the immunotherapy, via antigen spreading. "These data provide important new evidence supporting and elucidating the increase in overall survival of men with metastatic, castrate-resistant prostate cancer in our previously published Phase 2 study. PROSTVAC is now known to elicit an initial PSA targeted immune response. The key subsequent event is a broadened and personalized immune response against other tumor antigens through a process of epitope or antigen spreading," said James B. Breitmeyer, President of Bavarian Nordic's Cancer Immunotherapy Division. Bavarian Nordic will also be present at the conference with an exhibit, booth #2004 where attendees can learn more about PROSTVAC and the PROSPECT clinical trial - a global, randomized, double-blind, placebo-controlled Phase 3 study of PROSTVAC in men with asymptomatic and minimally symptomatic metastatic, castration-resistant prostate cancer. Bavarian Nordic will also host a PROSTVAC update and investor and analyst reception on Saturday, May 31, 2014 in Chicago, IL at 5 PM CDT. Confirmed speakers and panelists include Philip Kantoff, M.D. (Dana-Farber Cancer Institute), James L. Gulley, M.D., Ph.D. (NCI), Ravi A. Madan, M.D. (NCI), Larry Fong, M.D. (UCSF), Winald Gerritsen, M.D., Ph.D. (Radboud University Medical Centre Nijmegen) and James B. Breitmeyer, M.D., Ph.D. (Bavarian Nordic). For registration and more information on this event, visit http://www.bavarian- nordic.com/asco2014. Anders Hedegaard, President & CEO Contact Rolf Sass Sørensen, Vice President Investor Relations (EU). Phone +45 61 77 47 43 Seth Lewis, Vice President Investor Relations (US). Phone + 1 978-298-5654 About Bavarian Nordic Bavarian Nordic is an international biotechnology company developing and manufacturing novel cancer immunotherapies and vaccines for infectious diseases. Lead product candidates are PROSTVAC®, an immunotherapy product candidate for advanced prostate cancer that is the subject of an ongoing pivotal Phase 3 clinical trial, and IMVAMUNE®, a non-replicating smallpox vaccine candidate in Phase 3 development, which is being developed and supplied for emergency use to the U.S. Strategic National Stockpile under a contract with the U.S. Government. The vaccine is approved in Canada under the trade name IMVAMUNE and in the European Union under the trade name IMVANEX®. Bavarian Nordic's shares are listed on NASDAQ OMX Copenhagen under the symbol BAVA (Reuters: BAVA.CO, Bloomberg: BAVA.DC). The company has a sponsored Level 1 ADR program listed in the US (OTC) under the symbol BVNRY. For more information, visit www.bavarian-nordic.com. Forward-looking statements This announcement includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside of our control that could cause actual results to differ materially from the results discussed in the forward-looking statements. Forward-looking statements include statements concerning our plans, objectives, goals, future events, performance and/or other information that is not historical information. We undertake no obligation to publicly update or revise forward-looking statements to reflect subsequent events or circumstances after the date made, except as required by law. [HUG#1785650]

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Porte Brown Hits #3 for Young Accountants in 2026

Fresh Faces Rank Porte Brown High Now here's a thing most big-name firms might envy—Porte Brown nabbed the #3 spot on Accounting Today's 2026 list of Best Firms for Young Accountants. This isn't some fly-by-night recognition; it speaks to their whole gig—nurturing, training, and growing young talent in the world of numbers. When you talk about setting the bar for...

Bit Digital Shifts Focus: Q3 2026 Sees Strategic Moves

Bit Digital's Strategic Shakeup Ah, the digital gold rush is heating up again. Bit Digital, the outfit focused on Ethereum strategies and AI, dropped their financial results for Q3 2026. Picture a company at a strategic crossroads, shedding bitcoin mining baggage to grab hold of fresh opportunities in Ethereum staking and AI infrastructure. Bit Digital's earnings paint a...

Lululemon Lawsuit Looms: Investors Face Key Decisions

Seems Lululemon just tripped on its yoga mat. When a company like Lululemon Athletica, Inc (NASDAQ:LULU) sees a 17.38% slide in stock, every savvy investor knows there's more beneath the surface. Squarely in the crosshairs of a securities fraud class action, the brand synonymous with upscale athleisure faces harsh scrutiny. And the deadline's ticking—even the suits know...

Dexter Bowling BVL Event Series Honors Veterans

A Humble Roll to Honor Service Now, here's a heartwarming tale to chew over your morning coffee: Dexter Bowling is teaming up with the Bowlers to Veterans Link (BVL) for some feel-good festivities this holiday season. Beginning December, four special bowling events are rolling out across the U.S., designed just for veterans to connect over the camaraderie of spare strikes...

HSG Laser Boosts EU Presence with Düsseldorf Showroom

HSG Laser Makes a Bold Move in Europe When you're ripping off the band-aid and just diving into the hard truth, it's no small potatoes that HSG Laser has kicked open the doors to a shiny new showroom in Düsseldorf, Germany. This ain't just another brick in the wall—it's a sprawling 2,000 m² facility that marks a 20-year track record of tackling the European sector...

Kargo's Tech Boosts Profit on Seafood Supply Chain

Revolutionizing Seafood Logistics with Kargo You'd think managing seafood shipments would be a simpler gig than charting ocean routes, but think again. Northern Wind, a major player in seafood processing, just proved the power of tech in an old-school business by partnering with a slick AI outfit called Kargo. Their facility in New Bedford, Massachusetts now magically...

tZERO Gains CFTC Approval, Paves Derivatives Path

Breaking into New Territory: tZERO's CFTC Triumph tZERO just scored a touchdown in the financial arena with its newly minted approval from the Commodity Futures Trading Commission. This green light allows them to dive into derivatives trading and clearing, a colossal leap for their Infrastructure-as-a-Service model. You could almost feel the corporate chest-thumping as...

Global Youth Co-Creation Plan Inspires Deep Living

Rediscovering Authenticity in a Fast-Paced World In a world obsessed with snappy content and instant fame, it's refreshing to see an initiative like the Global Youth Image Co-creation Plan take center stage. Unveiled at the third Hong Kong Night, the plan isn't just another flash in the pan. No, it's a call—practically a rallying cry—for young creators worldwide to...

Oman's Hydrogen Expansion: New Projects, Big Ambitions

Oman's Green Hydrogen Strategy Takes Bold Steps Say what you will about Oman, they fancy themselves as the green hydrogen pioneers of the future. Here’s the kicker: they’ve just awarded two heavy-hitting green hydrogen projects in Duqm, and they’re not stopping there. Announced at COP31, this is their third auction’s pièce de résistance, asserting Oman’s green...

M-tron Industries Delivers Robust Q3 2026 Performance

Key Takeaways from M-tron's Q3 Results Well, M-tron Industries just put out numbers for Q3 2026 that’ve got the street buzzing. With 11.1% growth in revenues, their top-line performance ain't something to sniff at, especially when the defense and aerospace sectors drive the engine. They're not just coasting on momentum—there's some solid guidance here, with a backlog...